114 related articles for article (PubMed ID: 5068262)
1. [Distribution of exogenous and endogenous L-asparaginase in mice].
Wierer U; Pütter J
Arzneimittelforschung; 1972 Apr; 22(4):791-5. PubMed ID: 5068262
[No Abstract] [Full Text] [Related]
2. Pharmacokinetic behavior of L-asparaginase in men and in animals.
Pütter J
Recent Results Cancer Res; 1970; 33():64-74. PubMed ID: 5526349
[No Abstract] [Full Text] [Related]
3. Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized mice.
Baechtel S; Prager MD
Cancer Res; 1973 Aug; 33(8):1966-9. PubMed ID: 4578567
[No Abstract] [Full Text] [Related]
4. Inhibition of lymphoma 6C3HED by L-asparaginase from Serratia marcescens.
Boyd JW; Phillips AW
J Natl Cancer Inst; 1971 Jun; 46(6):1271-6. PubMed ID: 4932428
[No Abstract] [Full Text] [Related]
5. In vivo effects of intraperitoneally injected L-asparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, 'body' L-asparaginase, and plasma L-asparagine levels.
Siu Chong ED; Chang TM
Enzyme; 1974; 18(3):218-39. PubMed ID: 4601662
[No Abstract] [Full Text] [Related]
6. Transaminations of amino donors with alpha-ketoglutarate in normal and neoplastic mouse tissues measured by a simple radiometric procedure.
Simonsen DG; Roberts E
Biochem Med; 1974 May; 10(1):36-49. PubMed ID: 4597326
[No Abstract] [Full Text] [Related]
7. Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase.
Prager MD; Bachynsky N
Arch Biochem Biophys; 1968 Sep; 127(1):645-54. PubMed ID: 4880551
[No Abstract] [Full Text] [Related]
8. [The antitumor activity of L-asparaginase].
Adamson RH; Fabro S
Acta Vitaminol Enzymol; 1969; 23(3):111-24. PubMed ID: 4897937
[No Abstract] [Full Text] [Related]
9. [Study of glutaminase and asparaginase activities in normal tissues and malignant tumors].
Berezov TT
Ukr Biokhim Zh; 1966; 38(5):484-9. PubMed ID: 4298788
[No Abstract] [Full Text] [Related]
10. [Inhibition of the succino-dehydrogenase of animal tumors and normal tissues by 4-hydroxypentenal].
Kapfer E; Schauenstein E
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 77(3):180-8. PubMed ID: 4262172
[No Abstract] [Full Text] [Related]
11. [Absorption in vitro, by malignant cells, of serum proteins of rabbits and agoutis (l-asparaginase) conjugated with fluorescent substances].
Wanick LR
Rev Inst Antibiot (Recife); 1971 Jun; 11(1):39-42. PubMed ID: 5161610
[No Abstract] [Full Text] [Related]
12. Effect of a basic liver protein fraction on KB and Ehrlich ascites tumor cells.
Comoroşan S; Stănescu M; Solomon S; Gaşpar A; Vieru S; Sandru D; Soldatu M
Arch Geschwulstforsch; 1967; 28(4):320-7. PubMed ID: 5594755
[No Abstract] [Full Text] [Related]
13. Metabolism of proteins and glycoproteins in tumour bearing mice treated with Aeromonas L-asparaginase.
Benny PJ; Muraleedhara KG; Sreejith K; Jayashree G
Indian J Biochem Biophys; 1996 Dec; 33(6):527-30. PubMed ID: 9219441
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of animal tumors with L-asparaginase and antagonists of glutamine or glutamic acid.
Tarnowski GS; Mountain IM; Stock CC
Cancer Res; 1970 Apr; 30(4):1118-22. PubMed ID: 5504351
[No Abstract] [Full Text] [Related]
15. Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
Broome JD
Br J Cancer; 1968 Sep; 22(3):595-602. PubMed ID: 4878639
[No Abstract] [Full Text] [Related]
16. L-glutamine:D-fructose 6-phosphate amidotransferase in tumors and the liver of tumor-bearing animals.
Kikuchi H; Kobayashi Y; Tsuiki S
Biochim Biophys Acta; 1971 Jun; 237(3):412-21. PubMed ID: 4330266
[No Abstract] [Full Text] [Related]
17. [Experimental results in radiochemotherapy using L-asparaginase].
Ringleb D; Billger J; Busch E; Haeger V; Jung A; Kratz L
Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:192-3. PubMed ID: 4341092
[No Abstract] [Full Text] [Related]
18. [Experimental study of the antineoplastic activity of the antibiotic reumycin].
Navashin SM; Fomina IP; Koroleva VG; Terent'eva TG; Shtegal'man LA
Antibiotiki; 1967 Oct; 12(10):892-8. PubMed ID: 5631328
[No Abstract] [Full Text] [Related]
19. A factor responsible for the metabolic deviations in liver of tumor-bearing animals.
Tanaka T; Yanagi S; Miyahara M; Kaku R; Imamura K
Gan; 1972 Oct; 63(5):555-62. PubMed ID: 4645275
[No Abstract] [Full Text] [Related]
20. 51 Cr-L-asparagine accumulation by tumors: the influence of L-asparaginase treatment.
Anghileri LJ
J Nucl Biol Med; 1970; 14(4):150-2. PubMed ID: 5538035
[No Abstract] [Full Text] [Related]
[Next] [New Search]
